These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3815534)
1. Effects of the adjuvants SGP and Quil A on the induction of experimental autoimmune thyroiditis in mice. Williams WV; Kyriakos M; Sharp GC; Braley-Mullen H Cell Immunol; 1987 Feb; 104(2):296-303. PubMed ID: 3815534 [TBL] [Abstract][Full Text] [Related]
2. Immunopotentiation by SGP and Quil A. II. Identification of responding cell populations. Flebbe LM; Braley-Mullen H Cell Immunol; 1986 Apr; 99(1):128-39. PubMed ID: 3489558 [TBL] [Abstract][Full Text] [Related]
3. The role of cellular proliferation in the induction of experimental autoimmune thyroiditis (EAT) in mice. Williams WV; Kyriakos M; Sharp GC; Braley-Mullen H Cell Immunol; 1986 Nov; 103(1):96-104. PubMed ID: 3802208 [TBL] [Abstract][Full Text] [Related]
4. Immunopotentiating effects of the adjuvants SGP and Quil A. I. Antibody responses to T-dependent and T-independent antigens. Flebbe LM; Braley-Mullen H Cell Immunol; 1986 Apr; 99(1):119-27. PubMed ID: 3489557 [TBL] [Abstract][Full Text] [Related]
5. Augmentation of transfer of experimental autoimmune thyroiditis (EAT) in mice by irradiation of recipients. Williams WV; Kyriakos M; Sharp GC; Braley-Mullen H Cell Immunol; 1987 Oct; 109(2):397-406. PubMed ID: 2959375 [TBL] [Abstract][Full Text] [Related]
6. Activation of cytotoxic T cells and effector cells in experimental autoimmune thyroiditis by shared determinants of mouse and human thyroglobulins. Simon LL; Justen JM; Giraldo AA; Krco CJ; Kong YC Clin Immunol Immunopathol; 1986 May; 39(2):345-56. PubMed ID: 2421954 [TBL] [Abstract][Full Text] [Related]
7. The cellular basis for the Ia restriction in murine experimental autoimmune thyroiditis. Williams WV; Kyriakos M; Sharp GC; Braley-Mullen H Cell Immunol; 1987 Nov; 110(1):35-45. PubMed ID: 3499988 [TBL] [Abstract][Full Text] [Related]
8. Induction of experimental autoimmune thyroiditis in mice with in vitro activated splenic T cells. Braley-Mullen H; Johnson M; Sharp GC; Kyriakos M Cell Immunol; 1985 Jun; 93(1):132-43. PubMed ID: 3873286 [TBL] [Abstract][Full Text] [Related]
9. Induction of severe granulomatous experimental autoimmune thyroiditis in mice by effector cells activated in the presence of anti-interleukin 2 receptor antibody. Braley-Mullen H; Sharp GC; Bickel JT; Kyriakos M J Exp Med; 1991 Apr; 173(4):899-912. PubMed ID: 1672546 [TBL] [Abstract][Full Text] [Related]
10. Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis. Zhou JS; Gill HS Int J Food Microbiol; 2005 Aug; 103(1):97-104. PubMed ID: 16084270 [TBL] [Abstract][Full Text] [Related]
11. Regulation of the induction and resolution of granulomatous experimental autoimmune thyroiditis in mice by CD8+ T cells. Braley-Mullen H; McMurray RW; Sharp GC; Kyriakos M Cell Immunol; 1994 Feb; 153(2):492-504. PubMed ID: 8118878 [TBL] [Abstract][Full Text] [Related]
12. Distinctive modulation by IL-4 and IL-10 of the effector function of murine thyroglobulin-primed cells in "transfer-experimental autoimmune thyroiditis". Mignon-Godefroy K; Brazillet MP; Rott O; Charreire J Cell Immunol; 1995 May; 162(2):171-7. PubMed ID: 7743543 [TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor-alpha is a fundamental cytokine in autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide in interleukin-12 p40 deficient C57BL/6 mice. Zaccone P; Fehérvári Z; Cooke A Immunology; 2003 Jan; 108(1):50-4. PubMed ID: 12519302 [TBL] [Abstract][Full Text] [Related]
14. Characterization of resistance to murine experimental autoimmune thyroiditis: duration and afferent action of thyroglobulin- and TSH-induced suppression. Fuller BE; Okayasu I; Simon LL; Giraldo AA; Kong YM Clin Immunol Immunopathol; 1993 Oct; 69(1):60-8. PubMed ID: 7691454 [TBL] [Abstract][Full Text] [Related]
15. Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both Th1 and Th2 cytokines. Tang H; Braley-Mullen H Int Immunol; 1997 May; 9(5):679-87. PubMed ID: 9184913 [TBL] [Abstract][Full Text] [Related]
16. Differential requirement for autoantibody-producing B cells for induction of lymphocytic versus granulomatous experimental autoimmune thyroiditis. Braley-Mullen H; Sharp GC; Kyriakos M J Immunol; 1994 Jan; 152(1):307-14. PubMed ID: 8254200 [TBL] [Abstract][Full Text] [Related]
17. Prevention and reversal of experimental autoimmune thyroiditis (EAT) in mice by administration of anti-L3T4 monoclonal antibody at different stages of disease development. Stull SJ; Kyriakos M; Sharp GC; Braley-Mullen H Cell Immunol; 1988 Nov; 117(1):188-98. PubMed ID: 2902931 [TBL] [Abstract][Full Text] [Related]
18. Induction of granulomatous experimental autoimmune thyroiditis in mice with in vitro activated effector T cells and anti-IFN-gamma antibody. Stull SJ; Sharp GC; Kyriakos M; Bickel JT; Braley-Mullen H J Immunol; 1992 Sep; 149(6):2219-26. PubMed ID: 1517579 [TBL] [Abstract][Full Text] [Related]
19. Synergism between mouse thyroglobulin- and vaccination-induced suppressor mechanisms in murine experimental autoimmune thyroiditis. Nabozny GH; Flynn JC; Kong YC Cell Immunol; 1991 Sep; 136(2):340-8. PubMed ID: 1831404 [TBL] [Abstract][Full Text] [Related]
20. A thyroxine-containing thyroglobulin peptide induces both lymphocytic and granulomatous forms of experimental autoimmune thyroiditis. Braley-Mullen H; Sharp GC J Autoimmun; 1997 Dec; 10(6):531-40. PubMed ID: 9451592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]